Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.
- 2023-10-09
- Systematic Review · n = 380
- The Cochrane database of systematic reviews 2023(10)
- Martina Albertella
- Rahul R Gentyala
- Themistoklis Paraskevas
- Danielle Ehret
- Matteo Bruschettini
- Roger Soll
- PubMed: 37811631
- DOI: 10.1002/14651858.cd013232.pub2
- High evidence
- Clinical
mortality prior to discharge (RR 1.20, 95% CI 0.53 to 2.71; RD 0.04, 95% CI -0.14 to 0.23, 2 studies, 78 infants)
- Effect
- Neutral
- Effect size
- Small
- Significant
- No